Personal information

Countries

United Kingdom

Activities

Collapse all

Employment (5)

TopMD Precision Medicine Ltd: Southampton, Hampshire, GB

2021-06-01 to present | Director of R&D
Employment
Source: Self-asserted source
Erika Parkinson

University Hospitals Dorset NHS Foundation Trust: Bournemouth, Bournemouth, GB

2019-05-20 to 2022-03-30 | Clinical Research Manager (Research)
Employment
Source: Self-asserted source
Erika Parkinson

Solentim Ltd: Wimborne, Dorset, GB

2017-04-24 to 2019-02-13 | Head of R&D Biology (R&D)
Employment
Source: Self-asserted source
Erika Parkinson

University of Southampton: Southampton, Hampshire, GB

2012-01-01 to 2017-04-07 | Senior Research Fellow (Biological Sciences)
Employment
Source: Self-asserted source
Erika Parkinson

University of Southampton: Southampton, Hampshire, GB

2006-07-03 to 2011-12-31 | Research Fellow (Biological Sciences)
Employment
Source: Self-asserted source
Erika Parkinson

Education and qualifications (3)

Nottingham Trent University: Nottingham, Nottinghamshire, GB

2002-09-09 to 2006-05-30 | PhD (Life Sciences)
Education
Source: Self-asserted source
Erika Parkinson

University of Nottingham: Nottingham, Nottinghamshire, GB

2001-09-08 to 2002-08-31 | MSc Oncology (Medicine)
Education
Source: Self-asserted source
Erika Parkinson

Nottingham Trent University: Nottingham, Nottinghamshire, GB

1997-09-30 to 2001-07-11 | BSc (HONS) Applied Biology - Biomedical Science (Life Sciences)
Education
Source: Self-asserted source
Erika Parkinson

Professional activities (2)

Bournemouth University: Bournemouth, GB

2020-11-01 to present | Visiting Fellow (Health and Social Sciences)
Invited position
Source: Self-asserted source
Erika Parkinson

University of Southampton: Southampton, Hampshire, GB

2017-04 to present | Visiting Fellow (Biological Sciences)
Invited position
Source: Self-asserted source
Erika Parkinson

Works (17)

CycLing and EducATion (CLEAT): protocol for a single centre randomised controlled trial of a cycling and education intervention versus standard physiotherapy care for the treatment of hip osteoarthritis.

BMC musculoskeletal disorders
2023-05-03 | Journal article
DOI: 10.1186/s12891-023-06456-0
PMID: 37138278
PMC: PMC10155408
Contributors: Thomas Wainwright; Parkinson EP; Immins T; Docherty S; Elizabeth Goodwin; Annemarie Hawton; Low M; Samways J; Rees T; Saunders G et al.
Source: Self-asserted source
Erika Parkinson

Proteomic analysis of the cellular response to a potent sensitiser unveils the dynamics of haptenation in living cells

Toxicology
2020-12 | Journal article
DOI: 10.1016/j.tox.2020.152603
Part of ISSN: 0300-483X
Source: Self-asserted source
Erika Parkinson

Characterization of the Class I MHC Peptidome Resulting from DNCB Exposure of HaCaT Cells

Toxicological Sciences
2020-12-29 | Journal article
DOI: 10.1093/toxsci/kfaa184
Contributors: Alistair Bailey; Ben Nicholas; Rachel Darley; Erika Parkinson; Ying Teo; Maja Aleksic; Gavin Maxwell; Tim Elliott; Michael Ardern-Jones; Paul Skipp
Source: check_circle
Crossref

Proteomic Profiling of Archived Tissue of Primary Melanoma Identifies Proteins Associated with Metastasis.

International journal of molecular sciences
2020-10-31 | Journal article
DOI: 10.3390/ijms21218160
PMID: 33142795
PMC: PMC7663670
Contributors: Andrew Shapanis; Chester Lai; Sommerlad M; Parkinson E; Eugene Healy; Paul Skipp
Source: Self-asserted source
Erika Parkinson

Identification of proteins associated with development of metastasis from cutaneous squamous cell carcinomas (cSCCs) via proteomic analysis of primary cSCCs.

The British journal of dermatology
2020-08 | Journal article
DOI: 10.1111/bjd.19485
PMID: 32794257
Contributors: Shapanis A; Lai C; Smith S; Coltart G; Sommerlad M; Schofield J; Parkinson E; Skipp P; Healy E
Source: Self-asserted source
Erika Parkinson via Europe PubMed Central

What are the clinical, methodological, logistical and operational challenges when designing and conducting a randomised controlled trial of a group based intervention for the treatment of osteoarthritis and how can they be managed?

Osteoarthritis and Cartilage
2020-04 | Journal article
DOI: 10.1016/j.joca.2020.02.719
Part of ISSN: 1063-4584
Source: Self-asserted source
Erika Parkinson

Proteomic analysis of haptenation by skin sensitisers: Diphencyprone and ethyl acrylate.

Toxicology in vitro : an international journal published in association with BIBRA
2019-10 | Journal article
DOI: 10.1016/j.tiv.2019.104697
PMID: 31669365
Contributors: Parkinson E; Aleksic M; Arthur R; Regufe Da Mota S; Cubberley R; Skipp PJ
Source: Self-asserted source
Erika Parkinson via Europe PubMed Central

Biomarker discovery of proteins relevant to melanoma metastasis using a mass spectrometry approach

British Journal of Dermatology
2018-06 | Journal article
DOI: 10.1111/bjd.16590
Part of ISSN: 0007-0963
Source: Self-asserted source
Erika Parkinson

Biomarker discovery of metastasis in cutaneous squamous cell carcinoma using a mass spectrometry based proteomic approach

Journal of Investigative Dermatology
2018-05 | Journal article
DOI: 10.1016/j.jid.2018.03.158
Part of ISSN: 0022-202X
Source: Self-asserted source
Erika Parkinson

Determination of Protein Haptenation by Chemical Sensitizers Within the Complexity of the Human Skin Proteome.

Toxicological sciences : an official journal of the Society of Toxicology
2018-04 | Journal article
DOI: 10.1093/toxsci/kfx265
PMID: 29267982
PMC: PMC5889026
Contributors: Parkinson E; Aleksic M; Cubberley R; Kaur-Atwal G; Vissers JPC; Skipp P
Source: Self-asserted source
Erika Parkinson via Europe PubMed Central

Stable isotope labeling method for the investigation of protein haptenation by electrophilic skin sensitizers.

Toxicological sciences : an official journal of the Society of Toxicology
2014-08 | Journal article
DOI: 10.1093/toxsci/kfu168
PMID: 25145658
Contributors: Parkinson E; Boyd P; Aleksic M; Cubberley R; O'Connor D; Skipp P
Source: Self-asserted source
Erika Parkinson via Europe PubMed Central

Proteomic analysis of the human skin proteome after in vivo treatment with sodium dodecyl sulphate.

PloS one
2014-05 | Journal article
DOI: 10.1371/journal.pone.0097772
PMID: 24849295
PMC: PMC4029809
Contributors: Parkinson E; Skipp P; Aleksic M; Garrow A; Dadd T; Hughes M; Clough G; O'Connor CD
Source: Self-asserted source
Erika Parkinson via Europe PubMed Central

Response of T cells from DNCB-sensitised individuals to dinitrophenylated proteins in HaCaT cells

Journal of Investigative Dermatology
2011 | Journal article
DOI: 10.1038/jid.2011.214
Part of ISSN: 0022-202X
Source: Self-asserted source
Erika Parkinson

A qualitative and quantitative proteomic study of human microdialysate and the cutaneous response to injury.

The AAPS journal
2011-04 | Journal article
DOI: 10.1208/s12248-011-9269-6
PMID: 21494910
PMC: PMC3085710
Contributors: Gill C; Parkinson E; Church MK; Skipp P; Scott D; White AJ; O'Connor CD; Clough GF
Source: Self-asserted source
Erika Parkinson via Europe PubMed Central

An integrated proteomic and bioinformatic analysis for the diagnosis and prognosis of cancer.

2010-01 | Dissertation or Thesis
OTHER-ID:

442148
Contributors: Parkinson E
Source: Self-asserted source
Erika Parkinson via Europe PubMed Central

Assessment of transcriptomic and proteomic approaches to provide new molecular insights into consumer safety endpoints

Toxicology Letters
2008-10 | Journal article
DOI: 10.1016/j.toxlet.2008.06.695
Part of ISSN: 0378-4274
Source: Self-asserted source
Erika Parkinson

Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2005-08 | Journal article
DOI: 10.1200/jco.2005.03.164
PMID: 16051955
Contributors: Mian S; Ugurel S; Parkinson E; Schlenzka I; Dryden I; Lancashire L; Ball G; Creaser C; Rees R; Schadendorf D
Source: Self-asserted source
Erika Parkinson via Europe PubMed Central
How many people are using ORCID?